21 Invest France Acquires ProductLife Group

BC Partners and Bpifrance Acquire Biogaran from Servier

January 30, 2026

Pharmaceuticals

BC Partners and Bpifrance have completed the acquisition of Biogaran from Servier. The deal is supported by regulatory approvals (including EU clearances and French foreign investment screening), after a favourable opinion from Biogaran’s Social and Economic Committee.

ProductLife Group Acquires Halloran Consulting Group

October 17, 2024

Healthcare Services

ProductLife Group (PLG), a global life‑sciences consulting and outsourcing firm, has acquired Halloran Consulting Group, a U.S.-based life sciences consulting firm with offices in Boston and San Diego. The acquisition expands PLG’s regulatory, quality, clinical, and organizational capabilities while strengthening its presence in the North American market to better support pharmaceutical, biotech, and medical device clients.

ProductLife Group Acquires Outcomes'10

September 11, 2024

Consulting

ProductLife Group (PLG) has acquired Outcomes'10, a Spain-based market access and HEOR consultancy, to strengthen PLG’s European market access capabilities and expand its global market access platform. Outcomes'10 — headquartered in Castellón — will augment PLG’s services in pricing & reimbursement, health economics and outcomes research, and real-world evidence generation.

Oakley Capital Invests in ProductLife Group

May 28, 2024

Pharmaceuticals

Oakley Capital Fund V is investing in ProductLife Group, a European provider of outsourced development, regulatory and compliance services to the life sciences industry. Oakley will partner with management and reinvesting shareholder 21 Invest to support international expansion, accelerate AI-driven technology enablement, and pursue a buy-and-build strategy.

ProductLife Group Acquires Integrity

March 12, 2024

Consulting

ProductLife Group has acquired UK-based Integrity to strengthen its Digital consulting capabilities in life sciences, particularly IT Quality, Digital Project & Programme Management, and Computerized System Validation. The acquisition expands PLG's global Digital offering and supports accelerated growth into key markets including the UK, US and JAPAC.

Pace Life Sciences Acquires Biopharma Global

September 8, 2022

Healthcare Services

Pace Life Sciences, a CDMO subsidiary of Pace, has acquired Biopharma Global, a Vienna, Virginia-based regulatory affairs consultancy that specializes in orphan and other high‑unmet‑need drug regulatory support. The acquisition expands Pace's regulatory strategy and submission capabilities for FDA and EMA filings, strengthening its end-to-end development and regulatory services for biotech and pharmaceutical clients.